A Phase II Study of CRT Combined With QL1706 in ESCC Patients
Clinical trial NCT05490719 · UNKNOWN
Trial details
- NCT number
- NCT05490719
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-09-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.